Skip to main contentSkip to navigation
Sirius Investors
Pear Therapeutics, Inc.

Pear Therapeutics, Inc.

PEAR
NASDAQ•Healthcare

Market Capitalization & Enterprise Value

Research-grade valuation history for PEAR. Track market capitalization versus enterprise value to see the impact of net debt and share changes. Use the interactive chart to explore different horizons; the table updates accordingly to support auditability and export.

Quick links:Overview•Financial Metrics•Technicals•Returns•Financials•Performance

Market Cap & Enterprise Value

Comparison of market capitalization and enterprise value over time

Market Cap

Market Capitalization = Stock Price × Number of Shares Outstanding. Represents the total value of a company's equity.
163.67M
-88.12% over period
CAGR: -50.81%
Compound Annual Growth Rate - The mean annual growth rate over time, accounting for compounding effects.

Enterprise Value

Enterprise Value = Market Cap + Total Debt - Cash and Cash Equivalents. Represents the total value of a company including its debt.
152.98M
-88.80% over period
CAGR: -51.76%
Compound Annual Growth Rate - The mean annual growth rate over time, accounting for compounding effects.

Market Cap History

Investor Valuation Insights

As of Dec 31, 2022

EV/EBITDA

Distorted

-7.08x

Negative EV/EBITDA usually means negative EBITDA; compare with revenue and cash flow metrics.

EV vs Market Cap Spread

-10.69M

EV is -6.5% vs equity value

Capital Structure Signal

Net Cash Profile

EV premium trend: -5.6 pp vs earliest data

Additional Multiples

EV/Sales: 59.64x

Net Debt/EBITDA: 0.50x

Share count change in dataset: +0.66%

Interpretation guide: EV/EBITDA compares total firm value (debt + equity - cash) to operating earnings. Lower is usually cheaper, but always benchmark against peers, growth rate, margins, and cyclicality.

Market Cap & Enterprise Value Data

Free users can view the latest 3 records. Upgrade to see full history.

Upgrade
DateMarket CapEnterprise ValueStock PriceShares
Dec 31, 2022163.67M152.98M$1.18138.71M
Dec 31, 2021702.63M560.06M$6.20113.33M
Dec 31, 20201.38B1.29B$10.00137.80M
Dec 31, 2019
————

Enterprise Value Analysis

Price Change (Dec 2021 to Dec 2022)

The stock price has decreased from Dec 2021 to Dec 2022.
-80.97%

Recent Volatility

The stock price has been relatively volatile over the last 4 periods, indicating a higher risk profile.
0.33

Risk-Adjusted Return

The stock's returns do not compensate for its risk level, suggesting a poor risk-reward profile.
-1.20

Market Cap Change (Dec 2021 to Dec 2022)

The company's market capitalization has decreased from Dec 2021 to Dec 2022.
-76.71%

Enterprise Value Change (Dec 2021 to Dec 2022)

The company's enterprise value has decreased from Dec 2021 to Dec 2022, suggesting a decline in the company's total economic value.
-72.69%

Market Cap vs. Enterprise Value

A higher enterprise value growth rate compared to market cap growth could indicate that the company is investing heavily in growth initiatives or taking on more debt.
EV Growth > Market Cap Growth

Market Cap CAGR

The Compound Annual Growth Rate (CAGR) of market capitalization represents the mean annual growth rate over the entire available history (4 periods), accounting for compounding effects.
-50.81%

Enterprise Value CAGR

The Compound Annual Growth Rate (CAGR) of enterprise value represents the mean annual growth rate over the entire available history (4 periods), accounting for compounding effects.
-51.76%